Global K Cells Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Market Overview
The global K Cells market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The K Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
K Cells market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, K Cells market has been segmented into:
Mogamulizumab
Lorvotuzumab Mertansine
Others

By Application, K Cells has been segmented into:
Cancer
Cardiovascular Diseases
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global K Cells market presented in the report. This section sheds light on the sales growth of different regional and country-level K Cells markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global K Cells market.

The report offers in-depth assessment of the growth and other aspects of the K Cells market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and K Cells Market Share Analysis
K Cells competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, K Cells sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the K Cells sales, revenue and market share for each player covered in this report.

The major players covered in K Cells are:
Takeda Pharmaceutical (Japan)
Bristol-Myers Squibb (USA)
Sorrento Therapeutics Inc. (USA)
NantKwest Inc. (USA)
NKT Therapeutics (USA)

Table of Contents

1 K Cells Market Overview
1.1 Product Overview and Scope of K Cells
1.2 Classification of K Cells by Type
1.2.1 Global K Cells Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global K Cells Revenue Market Share by Type in 2019
1.2.3 Mogamulizumab
1.2.4 Lorvotuzumab Mertansine
1.2.5 Others
1.3 Global K Cells Market by Application
1.3.1 Overview: Global K Cells Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Others
1.4 Global K Cells Market by Regions
1.4.1 Global K Cells Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of K Cells (2015-2025)
1.4.3 North America (USA, Canada and Mexico) K Cells Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) K Cells Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) K Cells Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) K Cells Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) K Cells Status and Prospect (2015-2025)
2 Company Profiles
2.1 Takeda Pharmaceutical (Japan)
2.1.1 Takeda Pharmaceutical (Japan) Details
2.1.2 Takeda Pharmaceutical (Japan) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Takeda Pharmaceutical (Japan) SWOT Analysis
2.1.4 Takeda Pharmaceutical (Japan) Product and Services
2.1.5 Takeda Pharmaceutical (Japan) K Cells Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol-Myers Squibb (USA)
2.2.1 Bristol-Myers Squibb (USA) Details
2.2.2 Bristol-Myers Squibb (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bristol-Myers Squibb (USA) SWOT Analysis
2.2.4 Bristol-Myers Squibb (USA) Product and Services
2.2.5 Bristol-Myers Squibb (USA) K Cells Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sorrento Therapeutics Inc. (USA)
2.3.1 Sorrento Therapeutics Inc. (USA) Details
2.3.2 Sorrento Therapeutics Inc. (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sorrento Therapeutics Inc. (USA) SWOT Analysis
2.3.4 Sorrento Therapeutics Inc. (USA) Product and Services
2.3.5 Sorrento Therapeutics Inc. (USA) K Cells Revenue, Gross Margin and Market Share (2018-2019)
2.4 NantKwest Inc. (USA)
2.4.1 NantKwest Inc. (USA) Details
2.4.2 NantKwest Inc. (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 NantKwest Inc. (USA) SWOT Analysis
2.4.4 NantKwest Inc. (USA) Product and Services
2.4.5 NantKwest Inc. (USA) K Cells Revenue, Gross Margin and Market Share (2018-2019)
2.5 NKT Therapeutics (USA)
2.5.1 NKT Therapeutics (USA) Details
2.5.2 NKT Therapeutics (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 NKT Therapeutics (USA) SWOT Analysis
2.5.4 NKT Therapeutics (USA) Product and Services
2.5.5 NKT Therapeutics (USA) K Cells Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global K Cells Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 K Cells Players Market Share
3.2.2 Top 10 K Cells Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global K Cells Revenue and Market Share by Regions
4.2 North America K Cells Revenue and Growth Rate (2015-2020)
4.3 Europe K Cells Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific K Cells Revenue and Growth Rate (2015-2020)
4.5 South America K Cells Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa K Cells Revenue and Growth Rate (2015-2020)
5 North America K Cells Revenue by Countries
5.1 North America K Cells Revenue by Countries (2015-2020)
5.2 USA K Cells Revenue and Growth Rate (2015-2020)
5.3 Canada K Cells Revenue and Growth Rate (2015-2020)
5.4 Mexico K Cells Revenue and Growth Rate (2015-2020)
6 Europe K Cells Revenue by Countries
6.1 Europe K Cells Revenue by Countries (2015-2020)
6.2 Germany K Cells Revenue and Growth Rate (2015-2020)
6.3 UK K Cells Revenue and Growth Rate (2015-2020)
6.4 France K Cells Revenue and Growth Rate (2015-2020)
6.5 Russia K Cells Revenue and Growth Rate (2015-2020)
6.6 Italy K Cells Revenue and Growth Rate (2015-2020)
7 Asia-Pacific K Cells Revenue by Countries
7.1 Asia-Pacific K Cells Revenue by Countries (2015-2020)
7.2 China K Cells Revenue and Growth Rate (2015-2020)
7.3 Japan K Cells Revenue and Growth Rate (2015-2020)
7.4 Korea K Cells Revenue and Growth Rate (2015-2020)
7.5 India K Cells Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia K Cells Revenue and Growth Rate (2015-2020)
8 South America K Cells Revenue by Countries
8.1 South America K Cells Revenue by Countries (2015-2020)
8.2 Brazil K Cells Revenue and Growth Rate (2015-2020)
8.3 Argentina K Cells Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue K Cells by Countries
9.1 Middle East & Africa K Cells Revenue by Countries (2015-2020)
9.2 Saudi Arabia K Cells Revenue and Growth Rate (2015-2020)
9.3 UAE K Cells Revenue and Growth Rate (2015-2020)
9.4 Egypt K Cells Revenue and Growth Rate (2015-2020)
9.5 South Africa K Cells Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global K Cells Revenue and Market Share by Type (2015-2020)
10.2 Global K Cells Market Forecast by Type (2019-2024)
10.3 Mogamulizumab Revenue Growth Rate (2015-2025)
10.4 Lorvotuzumab Mertansine Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global K Cells Market Segment by Application
11.1 Global K Cells Revenue Market Share by Application (2015-2020)
11.2 K Cells Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Cardiovascular Diseases Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global K Cells Market Size Forecast (2021-2025)
12.1 Global K Cells Market Size Forecast (2021-2025)
12.2 Global K Cells Market Forecast by Regions (2021-2025)
12.3 North America K Cells Revenue Market Forecast (2021-2025)
12.4 Europe K Cells Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific K Cells Revenue Market Forecast (2021-2025)
12.6 South America K Cells Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa K Cells Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global K Cells Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of K Cells by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global K Cells Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market K Cells Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Takeda Pharmaceutical (Japan) Corporate Information, Location and Competitors
Table 6. Takeda Pharmaceutical (Japan) K Cells Major Business
Table 7. Takeda Pharmaceutical (Japan) K Cells Total Revenue (USD Million) (2017-2018)
Table 8. Takeda Pharmaceutical (Japan) SWOT Analysis
Table 9. Takeda Pharmaceutical (Japan) K Cells Product and Solutions
Table 10. Takeda Pharmaceutical (Japan) K Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bristol-Myers Squibb (USA) Corporate Information, Location and Competitors
Table 12. Bristol-Myers Squibb (USA) K Cells Major Business
Table 13. Bristol-Myers Squibb (USA) K Cells Total Revenue (USD Million) (2018-2019)
Table 14. Bristol-Myers Squibb (USA) SWOT Analysis
Table 15. Bristol-Myers Squibb (USA) K Cells Product and Solutions
Table 16. Bristol-Myers Squibb (USA) K Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sorrento Therapeutics Inc. (USA) Corporate Information, Location and Competitors
Table 18. Sorrento Therapeutics Inc. (USA) K Cells Major Business
Table 19. Sorrento Therapeutics Inc. (USA) K Cells Total Revenue (USD Million) (2017-2018)
Table 20. Sorrento Therapeutics Inc. (USA) SWOT Analysis
Table 21. Sorrento Therapeutics Inc. (USA) K Cells Product and Solutions
Table 22. Sorrento Therapeutics Inc. (USA) K Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. NantKwest Inc. (USA) Corporate Information, Location and Competitors
Table 24. NantKwest Inc. (USA) K Cells Major Business
Table 25. NantKwest Inc. (USA) K Cells Total Revenue (USD Million) (2017-2018)
Table 26. NantKwest Inc. (USA) SWOT Analysis
Table 27. NantKwest Inc. (USA) K Cells Product and Solutions
Table 28. NantKwest Inc. (USA) K Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. NKT Therapeutics (USA) Corporate Information, Location and Competitors
Table 30. NKT Therapeutics (USA) K Cells Major Business
Table 31. NKT Therapeutics (USA) K Cells Total Revenue (USD Million) (2017-2018)
Table 32. NKT Therapeutics (USA) SWOT Analysis
Table 33. NKT Therapeutics (USA) K Cells Product and Solutions
Table 34. NKT Therapeutics (USA) K Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Global K Cells Revenue (Million USD) by Players (2015-2020)
Table 36. Global K Cells Revenue Share by Players (2015-2020)
Table 37. Global K Cells Revenue (Million USD) by Regions (2015-2020)
Table 38. Global K Cells Revenue Market Share by Regions (2015-2020)
Table 39. North America K Cells Revenue by Countries (2015-2020)
Table 40. North America K Cells Revenue Market Share by Countries (2015-2020)
Table 41. Europe K Cells Revenue (Million USD) by Countries (2015-2020)
Table 42. Asia-Pacific K Cells Revenue (Million USD) by Countries (2015-2020)
Table 43. South America K Cells Revenue by Countries (2015-2020)
Table 44. South America K Cells Revenue Market Share by Countries (2015-2020)
Table 45. Middle East and Africa K Cells Revenue (Million USD) by Countries (2015-2020)
Table 46. Middle East and Africa K Cells Revenue Market Share by Countries (2015-2020)
Table 47. Global K Cells Revenue (Million USD) by Type (2015-2020)
Table 48. Global K Cells Revenue Share by Type (2015-2020)
Table 49. Global K Cells Revenue Forecast by Type (2021-2025)
Table 50. Global K Cells Revenue by Application (2015-2020)
Table 51. Global K Cells Revenue Share by Application (2015-2020)
Table 52. Global K Cells Revenue Forecast by Application (2021-2025)
Table 53. Global K Cells Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. K Cells Picture
Figure 2. Global K Cells Revenue Market Share by Type in 2019
Figure 3. Mogamulizumab Picture
Figure 4. Lorvotuzumab Mertansine Picture
Figure 5. Others Picture
Figure 6. K Cells Revenue Market Share by Application in 2019
Figure 7. Cancer Picture
Figure 8. Cardiovascular Diseases Picture
Figure 9. Others Picture
Figure 10. Global K Cells Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America K Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe K Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific K Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America K Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa K Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global K Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global K Cells Revenue Share by Players in 2019
Figure 18. Global Top 5 Players K Cells Revenue Market Share in 2019
Figure 19. Global Top 10 Players K Cells Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global K Cells Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global K Cells Revenue Market Share by Regions (2015-2020)
Figure 23. Global K Cells Revenue Market Share by Regions in 2018
Figure 24. North America K Cells Revenue and Growth Rate (2015-2020)
Figure 25. Europe K Cells Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific K Cells Revenue and Growth Rate (2015-2020)
Figure 27. South America K Cells Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa K Cells Revenue and Growth Rate (2015-2020)
Figure 29. North America K Cells Revenue Market Share by Countries (2015-2020)
Figure 30. North America K Cells Revenue Market Share by Countries in 2019
Figure 31. USA K Cells Revenue and Growth Rate (2015-2020)
Figure 32. Canada K Cells Revenue and Growth Rate (2015-2020)
Figure 33. Mexico K Cells Revenue and Growth Rate (2015-2020)
Figure 34. Europe K Cells Revenue Market Share by Countries (2015-2020)
Figure 35. Europe K Cells Revenue Market Share by Countries in 2019
Figure 36. Germany K Cells Revenue and Growth Rate (2015-2020)
Figure 37. UK K Cells Revenue and Growth Rate (2015-2020)
Figure 38. France K Cells Revenue and Growth Rate (2015-2020)
Figure 39. Russia K Cells Revenue and Growth Rate (2015-2020)
Figure 40. Italy K Cells Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific K Cells Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific K Cells Revenue Market Share by Countries in 2019
Figure 43. China K Cells Revenue and Growth Rate (2015-2020)
Figure 44. Japan K Cells Revenue and Growth Rate (2015-2020)
Figure 45. Korea K Cells Revenue and Growth Rate (2015-2020)
Figure 46. India K Cells Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia K Cells Revenue and Growth Rate (2015-2020)
Figure 48. South America K Cells Revenue Market Share by Countries (2015-2020)
Figure 49. South America K Cells Revenue Market Share by Countries in 2019
Figure 50. Brazil K Cells Revenue and Growth Rate (2015-2020)
Figure 51. Argentina K Cells Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa K Cells Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa K Cells Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia K Cells Revenue and Growth Rate (2015-2020)
Figure 55. UAE K Cells Revenue and Growth Rate (2015-2020)
Figure 56. Egypt K Cells Revenue and Growth Rate (2015-2020)
Figure 57. South Africa K Cells Revenue and Growth Rate (2015-2020)
Figure 58. Global K Cells Revenue Share by Type (2015-2020)
Figure 59. Global K Cells Revenue Share by Type in 2019
Figure 60. Global K Cells Market Share Forecast by Type (2021-2025)
Figure 61. Global Mogamulizumab Revenue Growth Rate (2015-2020)
Figure 62. Global Lorvotuzumab Mertansine Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global K Cells Revenue Share by Application (2015-2020)
Figure 65. Global K Cells Revenue Share by Application in 2019
Figure 66. Global K Cells Market Share Forecast by Application (2021-2025)
Figure 67. Global Cancer Revenue Growth Rate (2015-2020)
Figure 68. Global Cardiovascular Diseases Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global K Cells Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global K Cells Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global K Cells Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America K Cells Revenue Market Forecast (2021-2025)
Figure 74. Europe K Cells Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific K Cells Revenue Market Forecast (2021-2025)
Figure 76. South America K Cells Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa K Cells Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel

Choose License Type